Switch to Vildagliptin, oral hypoglycemic agent therapy, from Liraglutide injection (SWITCH-2)

Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
This article has no abstract
Epistemonikos ID: 86066aa65b1e74938953ba792cb845874fc283fd
First added on: Apr 16, 2025